Viewing StudyNCT00357396



Ignite Creation Date: 2024-05-05 @ 4:58 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00357396
Status: COMPLETED
Last Update Posted: 2015-11-25
First Post: 2006-07-26

Brief Title: Busulfan Melphalan and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewings Tumors
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Organization Data

Organization: Memorial Sloan Kettering Cancer Center
Class: OTHER
Study ID: 05-059
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH